SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003173
Filing Date
2018-04-25
Accepted
2018-04-25 16:31:17
Documents
9
Period of Report
2018-06-07
Effectiveness Date
2018-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235361zdef14a.htm DEF 14A 690435
2 G503223.JPG g503223.jpg GRAPHIC 15995
3 G760651.JPG g760651.jpg GRAPHIC 11677
4 G684915.JPG g684915.jpg GRAPHIC 8883
5 G171131.JPG g171131.jpg GRAPHIC 3949
6 G198114.JPG g198114.jpg GRAPHIC 3272
7 G603824.JPG g603824.jpg GRAPHIC 3928
8 G29812BGI001.GIF g29812bgi001.gif GRAPHIC 162456
9 G29812BGI002.GIF g29812bgi002.gif GRAPHIC 75356
  Complete submission text file 0001047469-18-003173.txt   1085646
Mailing Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715
Business Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36464 | Film No.: 18774738
SIC: 2834 Pharmaceutical Preparations